Antibody data
- Antibody Data
- Antigen structure
- References [5]
- Comments [0]
- Validations
- Western blot [1]
Submit
Validation data
Reference
Comment
Report error
- Product number
- 10393-1-AP - Provider product page
- Provider
- Proteintech Group
- Proper citation
- Proteintech Cat#10393-1-AP, RRID:AB_2083555
- Product name
- COMMD5 antibody
- Antibody type
- Polyclonal
- Description
- KD/KO validated COMMD5 antibody (Cat. #10393-1-AP) is a rabbit polyclonal antibody that shows reactivity with human, mouse and has been validated for the following applications: IF, IP, WB,ELISA.
- Reactivity
- Human, Mouse
- Host
- Rabbit
- Conjugate
- Unconjugated
- Isotype
- IgG
- Vial size
- 20ul, 150ul
Submitted references COMMD5 Inhibits Malignant Behavior of Renal Cancer Cells.
COMMD5/HCaRG Hooks Endosomes on Cytoskeleton and Coordinates EGFR Trafficking.
HCaRG/COMMD5 inhibits ErbB receptor-driven renal cell carcinoma.
HCaRG accelerates tubular repair after ischemic kidney injury.
Rosiglitazone suppresses gastric carcinogenesis by up-regulating HCaRG expression.
Ikeda J, Matsuda H, Ogasawara M, Ishii Y, Yamaguchi K, Takahashi S, Fukuda N, Masuhiro Y, Endo M, Soma M, Hamet P, Tremblay J
Anticancer research 2021 Jun;41(6):2805-2815
Anticancer research 2021 Jun;41(6):2805-2815
COMMD5/HCaRG Hooks Endosomes on Cytoskeleton and Coordinates EGFR Trafficking.
Campion CG, Zaoui K, Verissimo T, Cossette S, Matsuda H, Solban N, Hamet P, Tremblay J
Cell reports 2018 Jul 17;24(3):670-684.e7
Cell reports 2018 Jul 17;24(3):670-684.e7
HCaRG/COMMD5 inhibits ErbB receptor-driven renal cell carcinoma.
Matsuda H, Campion CG, Fujiwara K, Ikeda J, Cossette S, Verissimo T, Ogasawara M, Gaboury L, Saito K, Yamaguchi K, Takahashi S, Endo M, Fukuda N, Soma M, Hamet P, Tremblay J
Oncotarget 2017 Sep 19;8(41):69559-69576
Oncotarget 2017 Sep 19;8(41):69559-69576
HCaRG accelerates tubular repair after ischemic kidney injury.
Matsuda H, Lavoie JL, Gaboury L, Hamet P, Tremblay J
Journal of the American Society of Nephrology : JASN 2011 Nov;22(11):2077-89
Journal of the American Society of Nephrology : JASN 2011 Nov;22(11):2077-89
Rosiglitazone suppresses gastric carcinogenesis by up-regulating HCaRG expression.
Chen BL, Yu J, Zeng ZR, Chu WK, Wong CY, Cheng YY, Sung JJ, Hu PJ, Leung WK
Oncology reports 2008 Nov;20(5):1093-7
Oncology reports 2008 Nov;20(5):1093-7
No comments: Submit comment
Supportive validation
- Submitted by
- Proteintech Group (provider)
- Main image
- Experimental details
- The COMMD5 antibody from Proteintech is a rabbit polyclonal antibody to a recombinant protein of human COMMD5. This antibody recognizes human, mouse, rat antigen. The COMMD5 antibody has been validated for the following applications: ELISA, WB analysis.